16196391
Results 1 to 1 of 1
Selection :
A randomised phase II multicentre trial of irinotecan (CPT-II) using four different schedules in patients with metastatic colorectal cancerSCHOEMAKER, N. E; KUPPENS, I. E. L. M; VOZNYI, E et al.British journal of cancer. 2004, Vol 91, Num 8, pp 1434-1441, issn 0007-0920, 8 p.Article
